share_log

HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

Benzinga ·  Feb 19 12:16

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 257

Recommended

Write a comment